Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
Targets high-growth eye care expansion push
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated
